Estados financieros detallados de TuHURA Biosciences, Inc. (HURA): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Márgenes de los últimos 12 meses: margen bruto 0.0%, margen operativo 0.0%, margen neto 0.0%.
Al precio actual de $2.03, HURA presenta beneficios negativos (P/E no significativo) y un ROE del -154.32%. La capitalización bursátil es de $129M.
Cuenta de Resultados (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Coste de Ventas | $16683 | $24528 | $16348 | $10000 | $32000 | $60000 | $60000 | $55000 | 0 | 0 |
| Beneficio Bruto | -$16683 | -$24528 | -$16348 | -$10000 | -$32000 | -$60000 | -$60000 | -$55000 | 0 | 0 |
| I+D | $5.0M | $7.1M | $3.7M | $3.6M | $11.8M | $15.2M | $9.3M | $2.7M | $13.3M | $20.5M |
| Generales y Administrativos | $3.3M | $4.0M | $4.7M | $4.5M | $9.7M | $7.4M | $5.4M | $5.7M | $3.9M | $7.6M |
| Gastos Operativos | $8.3M | $11.2M | $8.4M | $8.1M | $21.5M | $22.6M | $14.7M | $8.4M | $17.6M | $31.8M |
| Beneficio Operativo | -$8.3M | -$11.2M | -$8.4M | -$8.1M | -$21.6M | -$22.7M | -$14.8M | -$8.5M | -$17.6M | -$31.8M |
| EBITDA | -$8.1M | -$11.1M | -$8.0M | -$9.1M | -$38.1M | -$22.0M | -$14.6M | -$8.3M | -$17.4M | -$29.4M |
| Gastos por Intereses | 0 | 0 | 0 | 0 | $120000 | $629286 | 0 | $18688 | $4.1M | $625283 |
| Beneficio Antes de Impuestos | -$8.1M | -$11.1M | -$8.0M | -$9.1M | -$38.3M | -$22.7M | -$14.6M | -$8.3M | -$21.7M | -$30.1M |
| Impuestos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$8.1M | -$11.1M | -$8.0M | -$9.1M | -$38.3M | -$22.7M | -$14.6M | -$8.3M | -$21.7M | -$30.1M |
| BPA | $-12950.00 | $-9491.47 | $-5524.99 | $-1532.00 | $-2805.84 | $-903.03 | $-324.48 | $-11.29 | $-1.21 | $-0.63 |
| BPA Diluido | $-12950.00 | $-9491.47 | $-5524.99 | $-1532.00 | $-2805.84 | $-903.03 | $-324.48 | $-11.29 | $-1.21 | $-0.63 |
| Acciones en Circulación (Diluidas) | $688 | $1192 | $1471 | $5968 | $14791 | $27829 | $46285 | $752914 | $18.7M | $47.9M |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Ingresos | 0 | 0 | 0 | 0 |
| Beneficio Bruto | 0 | 0 | -$23472 | 0 |
| Beneficio Operativo | -$6.7M | -$8.2M | -$7.5M | -$8.8M |
| EBITDA | -$7.1M | -$6.1M | -$7.5M | -$8.7M |
| Beneficio Neto | -$7.1M | -$6.8M | -$7.5M | -$9.2M |
| BPA | $-0.14 | $-0.13 | $-0.13 | $-0.14 |
| BPA Diluido | $-0.14 | $-0.13 | $-0.13 | $-0.14 |
Balance (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $6.6M | $6.0M | $3.7M | $2.4M | $10.5M | $5.5M | $14.3M | $3.7M | $12.7M | $3.6M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cuentas por Cobrar | $76595 | $39519 | $26187 | 0 | 0 | 0 | $101424 | $334443 | $222702 | 0 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $214699 | 0 |
| Activos Corrientes | $7.9M | $7.0M | $4.0M | $2.8M | $11.8M | $5.7M | $14.7M | $4.2M | $19.6M | $4.6M |
| Inmovilizado Material | 0 | 0 | 0 | $2000 | $150000 | $617139 | $418547 | $202990 | $322526 | $685169 |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $10.7M |
| Activos Intangibles | $40290 | $28411 | $12062 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $7.9M | $7.1M | $4.0M | $2.9M | $13.5M | $6.4M | $15.2M | $4.4M | $20.0M | $27.4M |
| Cuentas por Pagar | $1.3M | $1.5M | $1.7M | $2.0M | $2.2M | $413794 | $1.9M | $1.9M | $3.2M | $3.8M |
| Deuda a Corto | 0 | 0 | 0 | 0 | 0 | $644070 | 0 | 0 | 0 | $197354 |
| Pasivos Corrientes | $1.3M | $1.6M | $2.1M | $2.7M | $2.8M | $7.2M | $2.9M | $3.6M | $5.3M | $5.9M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $2.3M | 0 | $303627 |
| Pasivos Totales | $1.3M | $1.6M | $2.1M | $2.7M | $3.0M | $7.2M | $2.9M | $5.9M | $5.4M | $6.4M |
| Reservas | -$41.1M | -$52.4M | -$60.6M | -$69.7M | -$111.2M | -$49.5M | -$59.2M | -$88.5M | -$111.1M | -$141.2M |
| Patrimonio Neto | $6.6M | $5.4M | $2.0M | $263000 | $10.6M | -$747821 | $12.3M | -$1.6M | $14.6M | $20.9M |
| Deuda Total | 0 | 0 | 0 | 0 | 0 | $644070 | $138224 | $2.3M | $202542 | $700022 |
| Deuda Neta | -$6.6M | -$6.0M | -$3.7M | -$2.4M | -$10.5M | -$4.9M | -$14.1M | -$1.3M | -$12.5M | -$2.9M |
| Capital Circulante | $6.6M | $5.4M | $2.0M | $82000 | $9.0M | -$1.5M | $11.9M | $562422 | $14.3M | -$1.3M |
Balance (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caja y Equivalentes | $2.7M | $3.6M | $6.3M | $995977 |
| Activos Totales | $25.7M | $27.4M | $29.7M | $31.7M |
| Pasivos Totales | $8.9M | $6.4M | $6.5M | $13.2M |
| Patrimonio Neto | $16.8M | $20.9M | $23.2M | $18.5M |
| Deuda Total | $577732 | $700022 | $456926 | $407023 |
Flujo de Caja (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | -$8.1M | -$11.1M | -$8.0M | -$9.1M | -$38.3M | -$7.0M | -$9.4M | -$29.3M | -$21.7M | -$30.1M |
| Amortizaciones | $16683 | $24528 | $16348 | $10000 | $32000 | $380694 | $373093 | $177377 | $116710 | $71265 |
| Compensación en Acciones | 0 | 0 | 0 | 0 | 0 | $654529 | $218275 | $478890 | $2.0M | $6.4M |
| Cambio en Capital Circulante | -$478376 | $577514 | $1.1M | $487000 | -$2.7M | -$55000 | $1.6M | $486924 | $3.3M | -$3.1M |
| Flujo de Caja Operativo | -$8.0M | -$9.9M | -$6.3M | -$7.9M | -$18.9M | -$6.6M | -$7.5M | -$12.0M | -$14.7M | -$27.6M |
| Inversiones (CapEx) | 0 | $9.9M | $5 | 0 | -$8000 | -$3280 | -$36277 | -$79224 | -$57906 | -$76083 |
| Adquisiciones | 0 | 0 | 0 | 0 | $972000 | 0 | 0 | -$1.2M | -$6.0M | -$1.3M |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -$24751 | 0 | 0 |
| Dividendos Pagados | -$8356 | -$8356 | -$8356 | -$8000 | -$8000 | -$8000 | 0 | 0 | 0 | -$8356 |
| Flujo de Caja Libre | -$8.0M | 0 | -$6.3M | -$7.9M | -$18.9M | -$6.6M | -$7.5M | -$12.0M | -$14.8M | -$27.7M |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | -$11.1M | -$5.6M | -$4.4M | -$8.6M |
| Inversiones (CapEx) | 0 | -$27850 | -$48847 | -$136978 |
| Flujo de Caja Libre | -$11.1M | -$5.6M | -$4.5M | -$8.8M |
| Dividendos Pagados | -$2089 | -$2089 | -$2089 | -$2089 |
| Compensación en Acciones | $1.6M | $2.0M | 0 | $2.1M |
Crecimiento y Márgenes (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Beneficio Neto (anual) | | -37.8% | +27.7% | -13.4% | -319.7% | +40.8% | +35.4% | +43.2% | -160.6% | -38.6% |
| Crecimiento BPA (anual) | | +26.7% | +41.8% | +72.3% | -83.1% | +67.8% | +64.1% | +96.5% | +89.3% | +47.9% |
| Cambio en Acciones (anual) | | +73.2% | +23.4% | +305.7% | +147.8% | +88.1% | +66.3% | +1526.7% | +2378.7% | +156.8% |
| Crecimiento FCF (anual) | | +100.0% | | -25.3% | -138.0% | +65.2% | -14.9% | -59.5% | -22.9% | -87.4% |
| Tasa Impositiva Efectiva | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% |
Datos por Acción (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $-11648.77 | $0.00 | $-4301.44 | $-1328.42 | $-1275.64 | $-235.96 | $-163.00 | $-15.98 | $-0.79 | $-0.58 |
| Dividendo por Acción | $12.14 | $7.01 | $5.68 | $1.34 | $0.54 | $0.29 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $688 | $1192 | $1471 | $5968 | $14791 | $27829 | $46285 | $752914 | $18.7M | $47.9M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -154.32% |
| Rentabilidad sobre capital invertido | -137.40% |
| Rentabilidad sobre activos | -96.49% |
| Margen bruto | 0.00% |
| Margen operativo | 0.00% |
| Margen neto | 0.00% |
Salud financiera
| Deuda / Patrimonio | 0.02 |
| Ratio corriente | 0.18 |
Ratios Clave (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | -0.09 | -0.04 | -0.01 | -0.02 | -0.04 | -0.03 | -0.02 | -0.49 | -3.38 | -1.20 |
| P/VC | 0.12 | 0.07 | 0.05 | 0.78 | 0.16 | -0.95 | 0.03 | -2.69 | 5.23 | 1.73 |
| P/V | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Margen Bruto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Operativo | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Neto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |